Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03196427 PHASE2 COMPLETED Results posted

The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in pediatric participants with UC or CD.

Details

Lead sponsor	Takeda
Phase	PHASE2
Status	COMPLETED
Enrolment	59
Start date	Mon Jul 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jul 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Ulcerative Colitis
• Crohn's Disease

Interventions

• Vedolizumab

Countries

France, Ukraine, United Kingdom, Israel, Poland, Hungary, United States